Sorry, you need to enable JavaScript to visit this website.

    Pfizer Invites Public to View and Listen to Webcast of October 28 Analyst and Investor Meeting at ACR

    (BUSINESS WIRE)--Pfizer Inc invites investors, media and the general public to view and listen to a webcast of a presentation by Pfizers pain and inflammation leadership team at an analyst and investor meeting on Tuesday, October 28, 2008 at 6:00 p.m. Pacific Daylight Saving Time, in connection with the annual meeting of the American College of Rheumatology (ACR).

    To view and listen to the webcast, visit our web site homepage at www.pfizer.com and click on the Pfizer Analyst and Investor Meeting at ACR link in the Investor Presentations tab. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.

    Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com.

    Pfizer Inc
    Media Relations:
    Liz Power, 860-732-4987
    or
    Investor Relations:
    Jennifer Davis, 212-733-0717




    Sign up for the latest Pfizer Wire news alerts

    Receive real-time updates on Pfizer’s news delivered directly to your inbox.

    Our Pipeline: Potential Breakthroughs in the Making

    We're elevating our breakthroughs in a bold new way. Check out our new visualized product pipeline.

    Corporate Fact Sheet

    For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

    Media Asset Library

    Click here to view our media asset library.

    Pfizer Logo

    Our logo is shorthand for everything Pfizer represents: an image that is instantly identifiable to our colleagues, patients, the external scientific community, and the public.

    Executive Leadership

    Meet the executive leadership team, our senior-most leadership and decision-making management body who focus on major financial, strategic, and operational decisions for the entire company.

    Stay up to date on the latest news and alerts through the Pfizer Wire

    Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox. 

     

    Sign Up Now